Form 8-K - Current report:
SEC Accession No. 0001193125-25-135949
Filing Date
2025-06-05
Accepted
2025-06-05 16:57:42
Documents
12
Period of Report
2025-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d82912d8k.htm   iXBRL 8-K 36490
  Complete submission text file 0001193125-25-135949.txt   150616

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vrca-20250605.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20250605_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20250605_pre.xml EX-101.PRE 11261
14 EXTRACTED XBRL INSTANCE DOCUMENT d82912d8k_htm.xml XML 3618
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 251027888
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)